Literature DB >> 16875737

Bacterial complement evasion.

Suzan H M Rooijakkers1, Jos A G van Strijp.   

Abstract

The human complement system is elemental to recognize bacteria, opsonize them for handling by phagocytes, or kill them by direct lysis. However, successful bacterial pathogens have in turn evolved ingenious strategies to overcome this part of the immune system. In this review we discuss the different stages of complement activation sequentially and illustrate the immune evasion strategies that various bacteria have developed to evade each subsequent step. The focus is on bacterial proteins, either surface-bound or excreted, that block complement activation. The underlying molecular mechanism of action and the possible role in pathophysiology of bacterial infections are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16875737     DOI: 10.1016/j.molimm.2006.06.011

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  66 in total

1.  Convertase inhibitory properties of Staphylococcal extracellular complement-binding protein.

Authors:  Ilse Jongerius; Brandon L Garcia; Brian V Geisbrecht; Jos A G van Strijp; Suzan H M Rooijakkers
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

2.  Complement regulator Factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells.

Authors:  Vaibhav Agarwal; Tauseef M Asmat; Shanshan Luo; Inga Jensch; Peter F Zipfel; Sven Hammerschmidt
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

Review 3.  Complement-targeted therapeutics.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Nat Biotechnol       Date:  2007-11       Impact factor: 54.908

Review 4.  Complement evasion by human pathogens.

Authors:  John D Lambris; Daniel Ricklin; Brian V Geisbrecht
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

5.  Collagen-binding microbial surface components recognizing adhesive matrix molecule (MSCRAMM) of Gram-positive bacteria inhibit complement activation via the classical pathway.

Authors:  Mingsong Kang; Ya-Ping Ko; Xiaowen Liang; Caná L Ross; Qing Liu; Barbara E Murray; Magnus Höök
Journal:  J Biol Chem       Date:  2013-05-29       Impact factor: 5.157

Review 6.  Engineering antiphagocytic biomimetic drug carriers.

Authors:  Alicia Sawdon; Ching-An Peng
Journal:  Ther Deliv       Date:  2013-07

Review 7.  Anaphylatoxins: their role in bacterial infection and inflammation.

Authors:  Pieter-Jan Haas; Jos van Strijp
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

8.  Defining targets for complement components C4b and C3b on the pathogenic neisseriae.

Authors:  Lisa A Lewis; Sanjay Ram; Alpana Prasad; Sunita Gulati; Silke Getzlaff; Anna M Blom; Ulrich Vogel; Peter A Rice
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

9.  Binding of complement regulators to invasive nontypeable Haemophilus influenzae isolates is not increased compared to nasopharyngeal isolates, but serum resistance is linked to disease severity.

Authors:  Teresia Hallström; Fredrik Resman; Mikael Ristovski; Kristian Riesbeck
Journal:  J Clin Microbiol       Date:  2010-01-20       Impact factor: 5.948

10.  Genetic variants of complement genes ficolin-2, mannose-binding lectin and complement factor H are associated with leprosy in Han Chinese from Southwest China.

Authors:  Deng-Feng Zhang; Xian-Qiong Huang; Dong Wang; Yu-Ye Li; Yong-Gang Yao
Journal:  Hum Genet       Date:  2013-02-20       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.